2m 2m 2m 2m 2m 2m 2m
NUVALENT-A (NUVL)
NASDAQ
$123.75-$0.19 (-0.15%)
Price as of Jul 14, 2026 5:08 AM EDT- $9.1BMarket Cap
- 46.52%1-Year Change
- BiotechnologyIndustry
NUVALENT-A (NUVL)
$123.75-$0.19 (-0.15%)
Earnings Score
Valuation | NUVL | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NUVL | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 17.43% | ||
12-Month Momentum | 52.42% | ||
3-Month Risk Adjusted Momentum | 39.08% | ||
12-Month Risk Adjusted Momentum | 90.66% |
True Yield
Valuation | NUVL | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | NUVL | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |